• 

  What Can We Learn About Dementia from LGBTQ+ Brain Health Research?
• 

  Alzheon Alzheimer’s Pill Misses the Mark in Phase 3 Trial, Hints at Benefit in MCI
• 

  After Two Phase 3 Trial Fails, Cassava Sciences Gives Up On Alzheimer’s Drugs
• 

  No Kisunla in Europe: Regulators Reject Lilly’s Alzheimer’s ‘Mab’ Drug
• 

  23andMe to Sell Users’ Genetic Data in Bankruptcy Court — What You Need to Know
• 

  Long COVID 101: Patients and Doctors Explain the Condition
• 

  How Sex Hormones, Chromosomes, and Menopause Affect Women’s Brain Health
• 

  Research Into a COVID-Alzheimer’s Link Continues
• 

  Defying Genetic Destiny: The Man Whose Brain Resisted Early-Onset Alzheimer’s
• 

  Australia Is Latest Country to Say ‘No’ to Leqembi
• 

  Could a Chronic Gut Infection Trigger Alzheimer’s?
• 

  Do Statins Cause Dementia? Here’s What the Science Actually Says
• 

  Rising Microplastic Levels in the Brain: A Growing Concern
• 

  High-tech Headsets to Combat Alzheimer’s
• 

  TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2025.01)

Previous8910Next